Modulation of RANKL and osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis in response to disease‐modifying antirheumatic drug treatment and correlation with radiologic outcome

2008 ◽  
Vol 59 (7) ◽  
pp. 911-920 ◽  
Author(s):  
David Haynes ◽  
Tania Crotti ◽  
Helen Weedon ◽  
John Slavotinek ◽  
Virginia Au ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Drug Treatment ◽  
Synovial Tissue ◽  
Antirheumatic Drug ◽  
Disease Modifying ◽  
Disease Modifying Antirheumatic Drug

scholarly journals Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment

2017 ◽  
Vol 69 (3) ◽  
pp. 506-517 ◽  
Author(s):  
Roy Fleischmann ◽  
Michael Schiff ◽  
Désirée van der Heijde ◽  
Cesar Ramos-Remus ◽  
Alberto Spindler ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Drug Treatment ◽  
Antirheumatic Drug ◽  
Disease Modifying ◽  
Disease Modifying Antirheumatic Drug

scholarly journals Early combination disease modifying antirheumatic drug treatment for rheumatoid arthritis

2006 ◽  
Vol 184 (3) ◽  
pp. 122-125 ◽  
Author(s):  
Lynden J Roberts ◽  
Leslie G Cleland ◽  
Susanna M Proudman ◽  
Ranjeny Thomas
Keyword(s):  
Rheumatoid Arthritis ◽  
Drug Treatment ◽  
Antirheumatic Drug ◽  
Disease Modifying ◽  
Disease Modifying Antirheumatic Drug

scholarly journals Rheumatoid Arthritis Patients’ Motivations for Accepting or Resisting Disease-Modifying Antirheumatic Drug Treatment Regimens

2018 ◽  
Vol 70 (4) ◽  
pp. 533-541 ◽  
Author(s):  
Yomei Shaw ◽  
Ilinca D. Metes ◽  
Kaleb Michaud ◽  
Julie M. Donohue ◽  
Mark S. Roberts ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Drug Treatment ◽  
Antirheumatic Drug ◽  
Treatment Regimens ◽  
Disease Modifying ◽  
Disease Modifying Antirheumatic Drug
Sign in / Sign up

Export Citation Format

Share Document